The customer observed a falsely elevated total psa result for one (b)(6)-year old patient on the architect i1000sr analyzer.The following data was provided: initial (b)(6) 46.02 ng/ml, retested (b)(6) as 21.03 ng/ml.An mri was performed on (b)(6) and there was no signs of cancer.Free psa was tested as 3.586, 3.575, 3.581.There was no impact to patient management reported.
|
An evaluation is in process.A follow up report will be submitted when the evaluation is complete.(b)(4) no known impact or consequence to patient this report is being filed on an international product, architect total psa list 7k70 that has a similar product distributed in the us, list number 6c06.An evaluation is in process.
|